<table>
  <tr>
    <th>Cases</th>
    <th>Age at diagnosis (years); sex</th>
    <th>Histologic diagnosis; tumor location</th>
    <th>Prior surgery</th>
    <th>Prior therapy</th>
    <th>Age on treatment onset (years)</th>
    <th>Time on treatment (months)</th>
    <th>Best overall response</th>
    <th>Functional response</th>
    <th>Side effects</th>
  </tr>
  <tr>
    <td>Case 1</td>
    <td>1.5; F</td>
    <td>PA; medulla oblongata with leptomeningeal dissemination</td>
    <td>Biopsy</td>
    <td>CPT 11-CDDP; VBL</td>
    <td>5.8</td>
    <td>20</td>
    <td>PR</td>
    <td>Stable</td>
    <td>Skin (grade II)<br>Abdominal pain (grade II)<br>Cheilitis (grade I)<br>CPK and AP increased (grade I)</td>
  </tr>
  <tr>
    <td>Case 2</td>
    <td>0.5; M</td>
    <td>PMA; hypothalamic-chiasmatic</td>
    <td>Biopsy, PR</td>
    <td>VCR-CBCDA; 5 DR-BEV</td>
    <td>1</td>
    <td>18</td>
    <td>SD</td>
    <td>Stable</td>
    <td>Skin (grade I)<br>Cheilitis (grade I)</td>
  </tr>
  <tr>
    <td>Case 3</td>
    <td>0.9; F</td>
    <td>PA; intramedullary</td>
    <td>Biopsy</td>
    <td>VCR-CBCDA; CPT 11-CDDP</td>
    <td>12</td>
    <td>15</td>
    <td>SD</td>
    <td>Improvement of brachial hemiparesis, resolution of paresthesia in hands and torticollis</td>
    <td>Skin (grade II)<br>Alopecia (grade I)<br>Vasculitis (grade III)<br>CPK and ALT increased (grade I)</td>
  </tr>
  <tr>
    <td>Case 4</td>
    <td>1; M</td>
    <td>PMA; hypothalamic-chiasmatic</td>
    <td>Biopsy</td>
    <td>CPT 11-CDDP; VBL; BEV-CDDP; BEV</td>
    <td>7.5</td>
    <td>5</td>
    <td>SD</td>
    <td>Stable</td>
    <td>Skin (grade II)<br>Cheilitis (grade I)<br>Mucositis oral (grade I)<br>Abdominal pain (grade I)<br>Fatigue and anorexia (grade II)</td>
  </tr>
  <tr>
    <td>Case 5</td>
    <td>4.4; F</td>
    <td>PA; hypothalamic-chiasmatic</td>
    <td>Biopsy, PR</td>
    <td>CPT 11-CDDP; VBL; BEV-CDDP</td>
    <td>12.5</td>
    <td>8</td>
    <td>PD</td>
    <td>Visual deterioration</td>
    <td>Skin (grade II)<br>Alopecia (grade II)<br>Cheilitis (grade III)<br>Mucositis oral (grade II)<br>Fatigue and anorexia (grade II)</td>
  </tr>
  <tr>
    <td>Case 6</td>
    <td>5.8; F</td>
    <td>PA; intramedullary</td>
    <td>Biopsy, PR</td>
    <td>CPT 11-CDDP; VBL; BEV-CDDP</td>
    <td>12.3</td>
    <td>15</td>
    <td>SD</td>
    <td>Resolution of paresthesia in hands</td>
    <td>Skin (grade I)<br>Alopecia (grade I)<br>Mucositis oral (grade I)<br>CPK and LDH increased (grade I)</td>
  </tr>
  <tr>
    <td>Case 7</td>
    <td>0.8; F</td>
    <td>PMA; hypothalamic-chiasmatic</td>
    <td>Biopsy</td>
    <td>VCR-CBCDA; BEV</td>
    <td>2.8</td>
    <td>6</td>
    <td>PD</td>
    <td>Stable</td>
    <td>Skin (grade II)<br>Alopecia (grade I)</td>
  </tr>
  <tr>
    <td>Case 8</td>
    <td>1.8; M</td>
    <td>PA; hypothalamic-chiasmatic</td>
    <td>Biopsy</td>
    <td>VCR-CBCDA; VBL</td>
    <td>2.9</td>
    <td>6</td>
    <td>PD</td>
    <td>Increased hemiparesis and cranial nerve abnormalities</td>
    <td>Skin (grade I)</td>
  </tr>
  <tr>
    <td>Case 9</td>
    <td>3.9; M</td>
    <td>PA; hypothalamic-chiasmatic with leptomeningeal dissemination</td>
    <td>PR</td>
    <td>CPT 11-CDDP</td>
    <td>9.6</td>
    <td>14 (continue)</td>
    <td>SD</td>
    <td>Stable</td>
    <td>Skin (grade II)<br>Abdominal pain (grade I)<br>CPK increased (grade II)<br>AST and LDH increased (grade I)</td>
  </tr>
  <tr>
    <td>Case 10</td>
    <td>0.4; M</td>
    <td>PMA; hypothalamic-chiasmatic</td>
    <td>Biopsy, PR</td>
    <td>VCR-CBCDA; VBL-BEV</td>
    <td>1.8</td>
    <td>14 (continue)</td>
    <td>SD</td>
    <td>Diencephalic syndrome improvement</td>
    <td>Skin (grade II)<br>Abdominal pain (grade II)<br>Vomiting (grade I)<br>CPK increased (grade II)</td>
  </tr>
  <tr>
    <td>Case 11</td>
    <td>1.1; F</td>
    <td>GG; intramedullary</td>
    <td>Biopsy, PR</td>
    <td>CPT 11-CDDP; VBL; VCR-CBCDA; BEV-CPT 11</td>
    <td>10.8</td>
    <td>12 (continue)</td>
    <td>SD</td>
    <td>Stable</td>
    <td>Skin (grade I)<br>Cystitis (grade II)<br>Lymph gland infection (grade III)<br>LDH increased (grade I)</td>
  </tr>
</table>